cough medicine

Merck Co headquarters

UPDATE: FDA AdComm votes against Merck's cough med

An FDA advisory committee has voted against approving Merck's gefapixant, a medicine designed to treat chronic cough.

Gabrielle Masson Nov 17, 2023 4:53pm

Rollercoaster theme park fair ground

Aldeyra's roller coaster June ends with positive ph. 2 data

Jun 27, 2023 9:20am

GSK

GSK inks $2B Bellus buyout to challenge Merck for cough market

Apr 18, 2023 4:45am

calendar hour glass wait delay months

Merck responds to FDA letter for chronic cough med gefapixant

Aug 5, 2022 10:21am